MESO SCALE DIAGNOSTICS LLC Sustainability Profile
Meso Scale Diagnostics LLC, commonly referred to as MSD, is a leading biotechnology company headquartered in the United States. Founded in 2000, MSD has established itself as a key player in the life sciences industry, specialising in the development of innovative immunoassay platforms and biomarker solutions. With a strong presence in North America and Europe, the company offers a range of unique products, including its proprietary MULTI-ARRAY® technology, which enables high-throughput analysis of multiple biomarkers from a single sample. This capability sets MSD apart in the market, catering to the needs of researchers and clinicians in fields such as drug development, diagnostics, and personalised medicine. Recognised for its commitment to quality and innovation, Meso Scale Diagnostics continues to achieve significant milestones, solidifying its position as a trusted partner in advancing scientific research and healthcare solutions.
DitchCarbon Score
How does MESO SCALE DIAGNOSTICS LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
MESO SCALE DIAGNOSTICS LLC's score of 25 is lower than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
MESO SCALE DIAGNOSTICS LLC's reported carbon emissions
Meso Scale Diagnostics LLC, headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. The company is classified as a current subsidiary and inherits its climate commitments and data from its parent organisation, Meso Scale Diagnostics, LLC. Despite the lack of specific emissions data, Meso Scale Diagnostics LLC has not outlined any reduction targets or significant climate initiatives. The absence of commitments such as Science-Based Targets Initiative (SBTi) targets or other industry-standard climate pledges suggests that the company may still be in the early stages of formalising its climate strategy. As a subsidiary, Meso Scale Diagnostics LLC's climate performance and commitments may be influenced by the broader corporate family’s sustainability goals, but specific details on these initiatives are not provided. Overall, the company appears to have room for improvement in establishing measurable climate commitments and reporting its carbon footprint.
How Carbon Intensive is MESO SCALE DIAGNOSTICS LLC's Industry?
How Carbon Intensive is MESO SCALE DIAGNOSTICS LLC's Location?
MESO SCALE DIAGNOSTICS LLC's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
MESO SCALE DIAGNOSTICS LLC has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
